Form 4: Procore Technologies Director Kathryn Bueker Granted 3,049 Restricted Stock Units
Insider Transaction Report
Procore Technologies, Inc. director Kathryn Bueker was granted 3,049 restricted stock units, which will vest in 2026 and align her interests with long-term shareholder value.
Summary
- Kathryn Bueker, a Director of Procore Technologies, Inc. (PCOR), was granted 3,049 shares of common stock on June 5, 2025.
- These shares represent Restricted Stock Units (RSUs) acquired at a price of $0.
- Following this transaction, Ms. Bueker beneficially owns 19,981 shares of common stock.
- The RSUs are scheduled to vest 100% on the date of the issuer's 2026 annual meeting of stockholders, contingent on her continued service.
- Receipt of the common stock upon vesting has been deferred until the earlier of 90 days following termination of service or a change in control.
Sentiment
Score: 6
Explanation: The grant of Restricted Stock Units to a director is a routine and expected event that aligns the director's interests with long-term shareholder value. It is a standard compensation practice and does not indicate any significant positive or negative operational or financial developments for the company.
Positives
- Grant of 3,049 Restricted Stock Units (RSUs) to Director Kathryn Bueker aligns her interests with long-term shareholder value.
- The vesting schedule, tied to continued service through the 2026 annual meeting, incentivizes long-term commitment from the director.
Negatives
- The issuance of new shares upon RSU vesting will result in a minor dilution for existing shareholders, though this is a standard practice for equity compensation.
Risks
- No specific new risks are introduced or highlighted by this Form 4 filing beyond the inherent, minor dilution associated with equity compensation.
Future Outlook
The document primarily reports a past transaction and future vesting schedule, not broader company outlook or guidance.
Industry Context
This Form 4 filing reports a routine equity compensation grant to a director, which is a common practice across publicly traded companies in all industries to align management and director interests with shareholders. It does not provide specific industry trends or competitive analysis.
Comparison to Industry Standards
- The grant of Restricted Stock Units (RSUs) as a form of director compensation is a widely accepted and standard practice in corporate governance across various industries, including technology and software companies like Procore Technologies.
- This method is commonly used to incentivize long-term commitment and align the interests of directors with those of shareholders.
- No specific comparable companies or projects are mentioned in the document to allow for a detailed comparison of the grant size or terms.
Related Party Transactions
- The grant of Restricted Stock Units to Kathryn Bueker, a Director, constitutes a related party transaction, as it involves compensation from the company to a member of its board. This is a standard and disclosed form of related party dealing.
Stakeholder Impact
- Shareholders: Minor potential for dilution upon RSU vesting, but also improved alignment of director interests with long-term shareholder value.
Next Steps
- Vesting of 3,049 Restricted Stock Units on the date of the issuer's 2026 annual meeting of stockholders, subject to continued service.
- Issuance of common stock upon vesting, potentially deferred until 90 days post-termination or a change in control.
Key Dates
| Date | Description |
|---|---|
| 06/05/2025 | Date of RSU grant transaction. |
| 06/09/2025 | Date the Form 4 was signed by Attorney-in-Fact. |
| 2026 Annual Meeting | Expected vesting date for 100% of the RSUs, subject to continued service. |
Keywords
Procore Technologies, PCOR, Kathryn Bueker, Form 4, SEC filing, Restricted Stock Units, RSU, Insider transaction, Director compensation, Equity grant, Stock ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.